Michigan Biosciences Industry Association Logo

Advocacy

Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates BioConnections® Jobs Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
New Federal Legislation Seeks to Tighten Safeguards on Foreign Research Collaborations
Posted In: Federal Advocacy,
Date posted May 21

Michigan Congressman John Moolenaar, Chair of the House Select Committee on the Chinese Communist Party, has introduced the Securing Innovation...

Read Post
House Panel Advances Bill to Expand FDA Use of Animal Drug Testing Methods
Posted In: Federal Advocacy,
Date posted May 21

The House Energy & Commerce Committee’s Health Subcommittee has advanced bipartisan legislation aimed at accelerating the FDA’s...

Read Post
From Batch to Real-Time: FDA's New Trial Model Signals Opportunity for Innovators
Posted In: Federal Advocacy,
Date posted May 4

For decades, drug development has followed a predictable cadence: run a trial, wait, analyze, submit. Progress has often been defined as much by...

Read Post
Congress Pauses on Medicare Device Coverage Legislation as Admin. Rolls Out Rapid Access Initiative
Posted In: Federal Advocacy,
Date posted May 4

Momentum in Congress around Medicare coverage reform for medical devices appears to have slowed following the Administration’s introduction...

Read Post
MichBio Raises Concerns Over MFN Language in Senate DHHS Budget
Posted In: State Advocacy,
Date posted May 4

As the Michigan Senate considers the FY budget for the Department of Health and Human Services, MichBio is raising strong concerns about the...

Read Post
MichBio on Capitol Hill: Advancing Michigan's Voice in the National Biotech Policy Debate
Posted In: Federal Advocacy,
Date posted Apr 19

MichBio joined leaders from across the country in Washington, D.C. for the 2026 Council of StateBioscience Associations (CSBA) Fly-In, bringing...

Read Post
Biodefense Hearing in Ann Arbor: Key Takeaways
Posted In: Advocacy,
Date posted Apr 19

Michigan’s role in the national biosciences economy - and its importance to U.S. biodefense - took center stage on April 10 as the...

Read Post
SBIR/STTR Reauthorization Awaits Trump's Signature
Posted In: Federal Advocacy,
Date posted Apr 6

Congress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...

Read Post
Pharmaceutical Tariffs Raise Concerns for Innovation Economy and Emerging Biotech
Posted In: Federal Advocacy,
Date posted Apr 6

The White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...

Read Post
FY27 Budget Proposal Signals Continued Pressure on NIH, NSF, FDA — Raising Stakes for US Innovation
Posted In: Federal Advocacy,
Date posted Apr 6

The Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...

Read Post
FDA Guidance Links Study Design to 3-Year Exclusivity
Posted In: Federal Advocacy,
Date posted Mar 20

The FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...

Read Post
New Federal Legislation Targets "AI-ready" Biological Data to Accelerate Drug Development
Posted In: Federal Advocacy,
Date posted Mar 20

A bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...

Read Post